Press Releases about Ligand Pharm
Ligand Reports Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
Via Business Wire
Ligand to Report Fourth Quarter Financial Results on February 22
February 06, 2023
Via Business Wire
Ligand Provides Highlights from its Investor and Analyst Day Event
December 13, 2022
Via Business Wire
Ligand Pharmaceuticals Names Director Todd C. Davis as CEO
December 05, 2022
Via Business Wire
Ligand to Hold Investor and Analyst Day on December 13
November 16, 2022
Via Business Wire
Ligand Reports Third Quarter 2022 Financial Results
November 07, 2022
Via Business Wire
Ligand Announces Completion of OmniAb Spin-Off
November 01, 2022
Via Business Wire
Ligand to Report Third Quarter Financial Results on November 7
October 26, 2022
Via Business Wire
OmniAb Business Combination Approved by APAC Shareholders
October 24, 2022
Via Business Wire
Ligand Reports Second Quarter 2022 Financial Results
August 08, 2022
Via Business Wire
Ligand Reports Fourth Quarter and Full Year 2021 Financial Results
February 17, 2022
Via Business Wire
Ligand to Report Fourth Quarter Financial Results on February 17
February 09, 2022
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.